Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
CURRICULUM VITAE Name: Jerrold Michael Ward Education: 1966 1970 D.V.M. Cornell University Ph.D. Comparative Pathology, University of California, Davis Chronology of Employment: 1966 - 1970 Research Pathologist and NIH Trainee, Department of Veterinary Pathology, School of Veterinary Medicine University of California, Davis 1970 - 1971 Supervisory Veterinary Medical Officer, Bureau of Radiological Health, DHEW, PHS, Rockville, MD 1971 - 1972 Supervisory Veterinary Medical Officer (Veterinary Pathologist), Division of Research and Monitoring, Radiation Programs, Environmental Protection Agency, Rockville, MD 1972 - 1974 Supervisory Veterinary Medical Officer (Veterinary Pathologist), Carcinogen Metabolism and Toxicology Branch, Carcinogenesis, Division of Cancer Cause and Prevention, (DCCP), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 1974 - 1977 Supervisory Veterinary Medical Officer (Veterinary Pathologist), Laboratory of Toxicology, Division of Cancer Treatment, NCI, NIH, Bethesda, MD 1977 - 1978 Veterinary Medical Officer (Veterinary Pathologist), Tumor Pathology Branch, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, NCI, NIH, Bethesda, MD 1979 - 1981 Chief, Tumor Pathology, National Toxicology Program, NCI, NIH, Bethesda, MD 1981 - 1992 Chief, Tumor Pathology and Pathogenesis Section, Laboratory of Comparative Carcinogenesis, NCI, Frederick, MD 1992-1996 Chief, Veterinary and Tumor Pathology Section, Office of Laboratory Animal Science, Office of The Director, National Cancer Institute, Frederick, MD 1996-2000 Chief, Veterinary and Tumor Pathology Section, Office of Laboratory Animal Resources, Division of Basic Sciences, National Cancer Institute, Frederick, MD 2000 - 2004 Chief, Veterinary and Tumor Pathology Section, Center for Cancer Research, National Cancer Institute, Frederick, MD 2004 - 2008 Chief, Infectious Disease Pathogenesis Section, Comparative Medicine Branch, NIAID, NIH under contract to SoBran, Inc., Rockville, MD 2007Adjunct Professor, Department of Biomedical Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY 2008 Consultant in Veterinary Pathology Professional Organizations: Diplomate, American College of Veterinary Pathologists American Veterinary Medical Association Society of Toxicologic Pathology Professional Advisory and Consultant Activities: Member, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Chemicals that Cause Tumours of the Kidney or Urinary Bladder in Rodents and Some Other Substances, Volume 73, Lyon, France October 1998 Add Hoc Expert Member, EPA FIFRA Advisory Panel, 1999 Member, Committee on the Framework for Evaluating the Safety of Dietary Supplements, National Academy of Sciences, Food and Nutrition Board, Institute of Medicine, 2003-2004 Member, External Review Committee, Keldur Institute of Experimental Pathology, University of Iceland, Reykjavik, Iceland, October 2003 Member, InHand Committee on Nomenclature and Diagnostic Criteria in Toxicologic Pathology of The Immune System, Society of Toxicologic Pathology, 2005Member, InHand Commttee on The Nomenclature and Diagnostic Criteria in Toxicologic Pathology of The Liver, 2007 Organzer, Pathology of Mouse Models of Human Disease, The Jackson Laboratory, 2007 Member, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Metals, Particles and Fibres, Volume 100, March 2009 Book Chapters, Books and Syllabuses: 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. Ward, J. M.: Feline Infectious Peritonitis. In: Kirk, R. (Ed.): Current Veterinary Therapy IV. Philadelphia, PA, W. B. Saunders Co., 1971, pp. 658-659. Ward, J. M., Sagartz, J., and Casey, H.: Pathology of the Aging F344 Rat. Washington, D.C., Armed Forces Institute of Pathology, 1980, p.33. Bennett RS, Cress CM, Ward JM, Firestone CY, Murphy BR, Whitehead SS La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys. Virol J. 5:25, 2008 [Epub ahead of print]. Choukèr A, Lizak M, Schimel D, Helmberger T, Ward JM, Despres D, Kaufmann I, Bruns C, Löhe F, Ohta A, Sitkovsky MV, Klaunberg B, Thiel M. Comparison of Fenestra VC Contrast-enhanced computed tomography imaging with gadopentetate dimeglumine and ferucarbotran magnetic resonance imaging for the in vivo evaluation of murine liver damage after ischemia and reperfusion. Invest Radiol. 43:77-91, 2008. Choukèr A, Thiel M, Lukashev D, Ward JM, Kaufmann I, Apasov S, Sitkovsky MV, Ohta A. Critical Role of Hypoxia and A2A Adenosine Receptors in Liver Tissue-Protecting Physiological Anti-Inflammatory Pathway. Mol Med. 14:116-23, 2008. Hartley JW, Evans LH, Green KY, Naghashfar Z, Macias AR, Zerfas PM, Ward JM. Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line. Retrovirology. 5:1-, 2008. Shan W, Nicol CJ, Ito S, Bility MT, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM. Peroxisome proliferatoractivated receptor-beta/delta protects against chemically induced liver toxicity in mice. Hepatology. 47:22535, 2008. Ward JM. Value of rodent carcinogenesis bioassays. Toxicol Appl Pharmacol. 226:212, 2008. Maximova OA, Ward JM, Asher DM, St Claire M, Finneyfrock BW, Speicher JM, Murphy BR, Pletnev AG. Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in non-human primates. J Virol. 82: 5255-5268, 2008. Wancket LM, Devor-Henneman D, Ward JM. Fibro-osseous (FOL) and Degenerative Joint Lesions in Female Outbred NIH Black Swiss Mice. Toxicol Pathol. 36: 362-365, 2008. Gozalo AS, Cheng LI, St Claire ME, Ward JM, Elkins WR. Pathology of captive moustached tamarins (Saguinus mystax). Comp Med 58:188-95. 2008. Huter EN, Punkosdy GA, Glass DD, Cheng LI, Ward JM, Shevach EM. TGF-beta-induced Foxp3(+) regulatory T cells rescue scurfy mice. Eur J Immunol 38:1814-21, 2008. Yang L, Sanchez A, Ward JM, Murphy BR, Collins PL, Bukreyev A. A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals. Virology 377:255-64. 2008. Stummvoll GH, DiPaolo RJ, Huter EN, Davidson TS, Glass D, Ward JM, Shevach EM. Th1, th2, and th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J Immunol 181:1908-16. 2008. Oakley MS, McCutchan TF, Anantharaman V, Ward JM, Faucette L, Erexson C, Mahajan B, Zheng H, Majam V, Aravind L, Kumar S. Host Biomarkers and Biological Pathways that are Associated with the Expression of Experimental Cerebral Malaria in Mice. Infect Immun. 76:4518-4529, 2008. Gozalo AS, Maximova OA, StClaire MC, Montali RJ, Ward JM, Cheng LI, Elkins WR, Kazacos KR. Visceral and neural larva migrans in rhesus macaques. J Am Assoc Lab Anim Sci. 47:64-7, 2008. Ince TA, Ward JM, Valli VE, Sgroi D, Nikitin AY, Loda M, Griffey SM, Crum CP, Crawford JM, Bronson RT, Cardiff RD. Do-it-yourself (DIY) pathology. Nat Biotechnol. 26:978-9, 2008. Sood CL, Ward JM, Moss B. Vaccinia virus encodes a small hydrophobic virion membrane protein (I5) that enhances replication and virulence in mice. J Virol. 82:10071-8, 2008. Bility MT, Devlin-Durante MK, Blazanin N, Glick AB, Ward JM, Kang BH, Kennett MJ, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor-{beta}/{delta} (PPAR{beta}/{delta}) inhibits chemically-induced skin tumorigenesis. Carcinogenesis 29:2406-14, 2008. 2 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. Perdue KA, Copeland MK, Karjala Z, Cheng LI, Ward JM, Elkins WR. Suboptimal ability of dirty-bedding sentinels to detect Spironucleus muris in a colony of mice with genetic manipulations of the adaptive immune system. J Am Assoc Lab Anim Sci. 47:10-7, 2008. Waalkes MP, Liu J, Germolec DR, Trempus CS, Cannon RE, Tokar EJ, Tennant RW, Ward JM, Diwan BA. Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. Cancer Res. 68:8278-85, 2008. Bukreyev A, Yang L, Fricke J, Cheng L, Ward JM, Murphy BR, Collins PL. The secreted form of the G glycoprotein of respiratory syncytial virus helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes. J Virol 82:12191-204, 2008. Bolon B, Brayton C, Cantor GH, Kusewitt DF, Loy JK, Sartin EA, Schoeb TR, Sellers RS, Schuh JC, Ward JM. Editorial: best pathology practices in research using genetically engineered mice. Vet Pathol 45:939-40, 2008. Liu Q, Cheng LI, Yi L, Zhu N, Wood A, Changpriroa CM, Ward JM, Jackson SH. p47phox deficiency induces macrophage dysfunction resulting in progressive crystalline macrophage pneumonia. Am J Pathol 174:15363, 2009. Bukreyev A, Marzi A, Feldmann F, Zhang L, Yang L, Ward JM, Dorward DW, Pickles RJ, Murphy BR, Feldmann H, Collins PL. Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge. Virology 383:34861, 2009. Chi YH, Ward JM, Cheng LI, Yasunaga J, Jeang KT. Spindle assembly checkpoint and p53 deficiencies cooperate for tumorigenesis in mice. Int J Cancer. 124:1483-9, 2009. Buchholz UJ, Ward JM, Lamirande EW, Krempl CD, Collins PL. Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice (PVM) attenuates viral replication and reduces pulmonary cytokine expression and disease. J Virol. 2008 Dec 3. [Epub ahead of print] Chi YH, Cheng LI, Myers T, Ward JM, Williams E, Su Q, Faucette L, Wang JY, Jeang KT. Requirement for Sun1 in the expression of meiotic reproductive genes and piRNA. Development 136:965-73, 2009. Dinapoli JM, Ward JM, Cheng L, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A. Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virusvectored vaccines intended for humans. Vaccine 27:1530-9, 2009 Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, Johnson B, Johnson H, Pape J, Foster GA, Krysztof D, Follmann D, Stramer SL, Margolis LB, Murphy PM. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog. 2009 Feb;5(2):e1000321. Epub 2009 Feb 27. Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Guha N, Freeman C, Galichet L, Cogliano V; WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens--part C: metals, arsenic, dusts, and fibres. Lancet Oncol 10:453-4, 2009. Collin N, Gomes R, Teixeira C, Cheng L, Laughinghouse A, Ward JM, Elnaiem DE, Fischer L, Valenzuela JG, Kamhawi S. Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for leishmania. PLoS Pathog. 2009 May;5(5):e1000441. Epub 2009 May 22. Moayeri M, Crown D, Dorward DW, Gardner D, Ward JM, Li Y, Cui X, Eichacker P, Leppla SH. The Heart Is an Early Target of Anthrax Lethal Toxin in Mice: A Protective Role for Neuronal Nitric Oxide Synthase (nNOS). PLoS Pathog. 2009 May;5(5):e1000456. Epub 2009 May 29. 3